Deutsche Bank Ag\ Sol Gel Technologies Ltd. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$5.88 - $15.75 $482 - $1,291	-82 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.5 - $17.15 $47,632 - $108,919	-6,351 Reduced 98.73%	82 $1,000
Q3 2019 Nov 14, 2019	SELL	$7.7 - $10.48 $5,905 - $8,038	-767 Reduced 10.65%	6,433 $57,000
Q2 2019 Aug 14, 2019	BUY	$6.78 - $9.49 $48,816 - $68,328	7,200 New	7,200 $65,000
Q4 2018 Feb 14, 2019	SELL	$5.79 - $8.1 $13,317 - $18,630	-2,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.2 - $7.8 $14,260 - $17,940	2,300 New	2,300 $17,000

7.34M

5.4K

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $15M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.